
1. j trop med hyg. 2017 sep;97(3):744-752. doi: 10.4269/ajtmh.17-0254. epub 2017 
jul 27.

plasmodium vivax infections 3 years duffy blood group negative malians in
bandiagara, mali.

niangaly a(1), karthigayan gunalan(2), amed ouattara(3)(1), coulibaly d(1), s√°
jm(2), adams m(3), travassos ma(3), ferrero j(3), laurens mb(3), kone ak(1),
thera ma(1), plowe cv(3), miller lh(2), doumbo ok(1).

author information: 
(1)malaria research training center, international center excellence in
research, university sciences, techniques technology bamako, bamako,
mali.
(2)laboratory malaria vector research, national institutes allergy 
infectious diseases, national institutes health, rockville, maryland.
(3)division malaria research, institute global health, university of
maryland school medicine, baltimore, maryland.

plasmodium vivax thought infect erythrocytes duffy blood group
positive people. last decade, p. vivax appeared throughout africa,
both areas duffy positive negative people live side side in
madagascar ethiopia areas people primarily duffy negative,
such western kenya. performed quantitative polymerase chain reaction 
blood samples dried onto filter paper determine prevalence p. vivax and
plasmodium falciparum cohort 300 children (newborn 6 years age) 
bandiagara, sahelian area mali, west africa, people duffy
negative. report 1-3 occurrences p. vivax 25 duffy-negative
children six time points two rainy seasons beginning third
season. prevalence p. vivax infection 2.0-2.5% every time point
(june 2009 june 2010). children p. vivax infections asymptomatic
and afebrile, parasite densities extremely low. anemia, however, the
main burden infection. plasmodium vivax could become burden sub-saharan
africa, evidence p. vivax existence needs taken into
consideration designing malaria control elimination strategies africa.

doi: 10.4269/ajtmh.17-0254 
pmcid: pmc5590610
pmid: 28749772  [indexed medline]

